Aimmune Therapeutics Inc Ret. on assets
What is the Ret. on assets of Aimmune Therapeutics Inc?
The Ret. on assets of Aimmune Therapeutics Inc is -92.73%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Aimmune Therapeutics Inc
Companies with ret. on assets similar to Aimmune Therapeutics Inc
- Oceanic Wind has Ret. on assets of -93.34%
- OOOOO Entertainment Commerce has Ret. on assets of -93.10%
- Bidstack Plc has Ret. on assets of -93.00%
- InMed Pharmaceuticals has Ret. on assets of -92.93%
- Kopin has Ret. on assets of -92.85%
- Copperbank Resources has Ret. on assets of -92.75%
- Aimmune Therapeutics Inc has Ret. on assets of -92.73%
- Matinas Biopharma Inc has Ret. on assets of -92.70%
- Nordic Nanovector ASA has Ret. on assets of -92.69%
- Pressure BioSciences has Ret. on assets of -92.58%
- Pressure BioSciences has Ret. on assets of -92.58%
- Pressure BioSciences has Ret. on assets of -92.58%
- Reward Minerals has Ret. on assets of -92.54%